+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Blood Culture Test Market (2021-2026) by Product, Method, Technology, Application, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5503422
  • Report
  • September 2021
  • Region: Global
  • 177 Pages
  • Infogence Global Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Autobio Diagnostics Co
  • Bruker Corporation
  • Carl Zeiss AG
  • HiMedia Laboratories
  • Merck Millipore
The Global Blood Culture Test Market is estimated to be USD 4.2 Bn in 2021 and is expected to reach USD 6.5 Bn by 2026, growing at a CAGR of 9%.



Market Dynamics

The major factor leading the growth of the global blood culture test market is the upsurge in the prevalence of infectious diseases such as sepsis, meningitis, osteomyelitis, pneumonia, etc. In addition, an increase in the geriatric population, raising awareness of diagnosis, and increasing public and private healthcare expenditure have escalated the market growth. Developing demand for point-of-care and rapid diagnostic tests, and increasing acceptance of new technologies are escalating the market growth. The market is presumed to observe substantial growth because of technological advancements in terms of automation, cost-effectiveness, and product innovation.

Though, the unavailability of skillful specialists & laboratory technicians and the high cost of automated blood culture instruments are anticipated to hinder the growth of the market.

Market Segmentation

The Global Blood Culture Test Market is segmented further based on Product, Method, Technology, Application, End-User, and Geography.

By Product, the market is classified as Consumables, Instruments, and Software & Services. Amongst all, the Consumables segment is estimated to hold the highest market share during the forecast period.

By Method, the market is classified as Conventional Methods and Automated Methods. Amongst the two, the Conventional Methods segment is estimated to hold the highest market share during the forecast period.

By Technology, the market is classified as Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-Fish (Peptide Nucleic Acid - Fluorescent In Situ Hybridization), and Proteomics Technology. The Molecular Technologies segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as Bacteremia, Fungemia, and Mycobacterial Detection. Amongst all, the Mycobacterial Detection segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified as Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, and Others. The Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. bioMérieux had received FDA clearance to extend platelet shelf life to 7 days with a Large Volume Delayed Sampling strategy using BACT/ALERT 3D and BACT/ALERT VIRTUO culture systems. - 25th May 2020
2. Bruker has Introduced MBT Sepsityper Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures on the MALDI Biotyper CA System– 4th January 2021

Company Profiles

Some of the companies covered in this report are Becton, Dickinson, and Company, Agilent, Biobase Biotech (Jinan), bioMérieux, Bruker, Carl Zeiss, Danaher, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Blood Culture Test Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Blood Culture Test Market

What is the estimated value of the Global Blood Culture Test Market?

The Global Blood Culture Test Market was estimated to be valued at $4200.0 Million in 2021.

What is the growth rate of the Global Blood Culture Test Market?

The growth rate of the Global Blood Culture Test Market is 9.1%, with an estimated value of $6500.0 Million by 2026.

What is the forecasted size of the Global Blood Culture Test Market?

The Global Blood Culture Test Market is estimated to be worth $6500.0 Million by 2026.

Who are the key companies in the Global Blood Culture Test Market?

Key companies in the Global Blood Culture Test Market include Anaerobe Systems, Axiom Laboratories, Autobio Diagnostics Co, Becton, Dickinson, and Company, Agilent Technologies, Inc., Biobase Biotech (Jinan) Co.Ltd., Bruker Corporation, Bulldog Bio, Inc. and Danaher Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Autobio Diagnostics Co
  • Bruker Corporation
  • Carl Zeiss AG
  • HiMedia Laboratories
  • Merck Millipore

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Demand for Point-Of-Care & Rapid Diagnostic Tests
4.1.2 Growing Prevalence of Infectious Diseases
4.1.3 Rising Geriatric Population
4.1.4 Growing Number of Sepsis Cases and Bloodstream Infections
4.1.5 Rising Public and Private Healthcare Expenditure
4.2 Restraints
4.2.1 Stringent Regulations and Regulatory Approvals
4.2.2 Unstable Reimbursement Policy
4.2.3 High Cost of Automated Instruments
4.3 Opportunities
4.3.1 Growing Popularity of Advanced Diagnostic Techniques
4.3.2 Burgeoning Approval Rate of New Products
4.3.3 Increasing Healthcare Facilities in Emerging Countries
4.3.4 Identification of antibiotic-resistant microorganisms
4.4 Challenges
4.4.1 Lack of Skilled Professionals
4.4.2 Market cannibalization
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Blood Culture Test Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Blood Culture Media
6.2.1.1 Aerobic Blood Culture Media
6.2.1.2 Pediatric Aerobic Blood Culture Media
6.2.1.3 Anaerobic Blood Culture Media
6.2.1.4 Mycobacterial Blood Culture Media
6.2.1.5 Fungi/Yeast Blood Culture Media
6.2.2 Assay Kits & Reagents
6.2.3 Blood Culture Accessories
6.3 Instruments
6.3.1 Automated Blood Culture Systems
6.3.2 Supporting Laboratory Equipment
6.3.2.1 Incubators
6.3.2.2 Colony Counters
6.3.2.3 Microscopes
6.3.2.4 Gram Strainers
6.4 Software & Services
7 Global Blood Culture Test Market, By Method
7.1 Introduction
7.2 Conventional Methods
7.3 Automated Methods
8 Global Blood Culture Test Market, By Technology
8.1 Introduction
8.2 Culture-Based Technology
8.3 Molecular Technologies
8.4 Microarrays
8.5 PCR (Polymerase Chain Reaction)
8.6 PNA-FISH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization)
8.7 Proteomics
9 Global Blood Culture Test Market, By Application
9.1 Introduction
9.2 Bacteraemia
9.3 Fungemia
9.4 Mycobacterial Detection
10 Global Blood Culture Test Market, By End User
10.1 Introduction
10.2 Hospital Laboratories
10.3 Reference Laboratories
10.4 Academic Research Laboratories
10.5 Others
11 Global Blood Culture Test Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 South America
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Chile
11.3.4 Colombia
11.4 Europe
11.4.1 UK
11.4.2 France
11.4.3 Germany
11.4.4 Italy
11.4.5 Spain
11.4.6 Netherlands
11.4.7 Sweden
11.4.8 Russia
11.4.9 Rest of Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Indonesia
11.5.5 Malaysia
11.5.6 South Korea
11.5.7 Australia
11.5.8 Sri Lanka
11.5.9 Thailand
11.5.10 Rest of APAC
11.6 Middle-East and Africa
11.6.1 Qatar
11.6.2 Saudi Arabia
11.6.3 South Africa
11.6.4 United Arab Emirates
12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Anaerobe Systems
13.2 Axiom Laboratories
13.3 Autobio Diagnostics Co
13.4 Becton, Dickinson, and Company
13.5 Agilent Technologies, Inc.
13.6 Biobase Biotech (Jinan) Co.Ltd.
13.7 Bruker Corporation
13.8 Bulldog Bio, Inc.
13.9 Carl Zeiss AG
13.10 Danaher Corporation
13.11 HiMedia Laboratories
13.12 Luminex Corporation
13.13 Meditech Technologies India Pvt Ltd
13.14 OpGen
13.15 Abbott Laboratorie
13.16 Scenker Biological Technology Co., Ltd
13.17 T2 Biosystems
13.18 Thermo Fisher Scientific
13.19 Mindray Medical International Limited
13.20 Siemens Healthineers AG
13.21 Merck Millipore
13.22 Perkin Elmer Inc.
13.23 Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
14 Appendix
14.1 Questionnaire
Note: Product cover images may vary from those shown
  • Anaerobe Systems
  • Axiom Laboratories
  • Autobio Diagnostics Co
  • Becton, Dickinson, and Company
  • Agilent Technologies, Inc.
  • Biobase Biotech (Jinan) Co.Ltd.
  • Bruker Corporation
  • Bulldog Bio, Inc.
  • Carl Zeiss AG
  • Danaher Corporation
  • HiMedia Laboratories
  • Luminex Corporation
  • Meditech Technologies India Pvt Ltd
  • OpGen
  • Abbott Laboratories
  • Scenker Biological Technology Co., Ltd
  • T2 Biosystems
  • Thermo Fisher Scientific
  • Mindray Medical International Limited
  • Siemens Healthineers AG
  • Merck Millipore
  • Perkin Elmer Inc.
  • Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
Note: Product cover images may vary from those shown